Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN954471 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-RB-Associated KRAB Zinc Finger (RBAK) (AA 73-102), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 73-102
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.
Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.
No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II.
Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.
Trynka G, Zhernakova A, Romanos J, Franke L, Hunt KA, Turner G, Bruinenberg M, Heap GA, Platteel M, Ryan AW, de Kovel C, Holmes GK, Howdle PD, Walters JR, Sanders DS, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, Kelleher D, Barisani D, Bardella MT, McManus R, van Heel DA, Wijmenga C
Gut 2009 Aug;58(8):1078-83
Gut 2009 Aug;58(8):1078-83
Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II.
Jeske YW, So A, Kelemen L, Sukor N, Willys C, Bulmer B, Gordon RD, Duffy D, Stowasser M
Clinical and experimental pharmacology & physiology 2008 Apr;35(4):380-5
Clinical and experimental pharmacology & physiology 2008 Apr;35(4):380-5
No evidence for coding region mutations in the retinoblastoma-associated Kruppel-associated box protein gene (RBaK) causing familial hyperaldosteronism type II.
So A, Jeske YW, Gordon RD, Duffy D, Kelemen L, Stowasser M
Clinical endocrinology 2006 Dec;65(6):829-31
Clinical endocrinology 2006 Dec;65(6):829-31
Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics.
Vertegaal AC, Andersen JS, Ogg SC, Hay RT, Mann M, Lamond AI
Molecular & cellular proteomics : MCP 2006 Dec;5(12):2298-310
Molecular & cellular proteomics : MCP 2006 Dec;5(12):2298-310
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB